NorthRock Partners, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1632097
MINNEAPOLIS, MN
Position in VRTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$552,860
+$71,044 QoQ
Shares Held
1,113
+3.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,036
of 1,735 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NorthRock Partners, LLC holds $1,787,469 across 5 Biotechnology names. VRTX ranks #1 (30.9% of the industry book) .
All Filings in VRTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $552,860 | 1,113 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $481,816 | 1,079 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $491,895 | 1,085 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,351,941 | 3,452 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,413,955 | 3,176 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,587,300 | 3,274 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,177,897 | 2,925 | Shares | Sole | 2025-04-22 | |
| 2024-09-30 | $1,535,694 | 3,302 | Shares | Sole | 2025-04-22 | |
| 2024-06-30 | $1,516,309 | 3,235 | Shares | Sole | 2025-04-22 | |
| 2024-03-31 | $1,297,085 | 3,103 | Shares | Sole | 2025-04-22 | |
| 2023-12-31 | $1,148,243 | 2,822 | Shares | Sole | 2025-04-22 | |
| 2023-09-30 | $517,784 | 1,489 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $343,112 | 975 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $275,371 | 874 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $326,032 | 1,129 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $282,011 | 974 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $261,219 | 927 | Shares | Sole | 2022-08-04 | |
| No filing history on record for this holder in this stock. | ||||||